Xcelience Opens New Headquarters
PTSM: Pharmaceutical Technology Sourcing and Management
CDMO Xcelience opens new facility in Tampa, FL, for formulation and analytical services.
Xcelience opened a 71,000-sq-ft headquarters facility in Tampa, FL on Oct. 30, 2015.
Xcelience, a contract development and manufacturer (CDMO), has announced the opening of a new 71,000-sq-ft headquarters at 4910 Savarese Circle in Tampa, FL. The building houses preformulation and formulation development labs and suites, executive headquarters, and analytical and stability services. An official ribbon cutting ceremony on Oct. 30, 2015 was attended by Florida Governor Rick Scott, Tampa Mayor Bob Buckhorn, and other elected and non-elected officials.
The company’s previous headquarters on West Laurel Street in Tampa will transition to provide clinical trial and small-scale commercial manufacturing.
In July 2015, Xcelience made a structured cash investment in Powdersize, a Pennsylvania-based company specializing in milling, micronization, and powder size, adding particle size control solutions to Xcelience’s portfolio of capabilities.
Xcelience provides services from preformulation through global clinical supplies packaging and distribution to international pharmaceutical and biotechnology clients for Phases I-IV. Since its inception in 2006, the company has grown from one facility with 45 employees to an international CDMO provider, with seven facilities and more than 200 employees.
Source: Xcelience
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
